176 related articles for article (PubMed ID: 31554961)
1. ERK1/2-HNF4α axis is involved in epigallocatechin-3-gallate inhibition of HBV replication.
Wang ZY; Li YQ; Guo ZW; Zhou XH; Lu MD; Xue TC; Gao B
Acta Pharmacol Sin; 2020 Feb; 41(2):278-285. PubMed ID: 31554961
[TBL] [Abstract][Full Text] [Related]
2. Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication - inducible cell line.
He W; Li LX; Liao QJ; Liu CL; Chen XL
World J Gastroenterol; 2011 Mar; 17(11):1507-14. PubMed ID: 21472112
[TBL] [Abstract][Full Text] [Related]
3. Mucroporin-M1 inhibits hepatitis B virus replication by activating the mitogen-activated protein kinase (MAPK) pathway and down-regulating HNF4α in vitro and in vivo.
Zhao Z; Hong W; Zeng Z; Wu Y; Hu K; Tian X; Li W; Cao Z
J Biol Chem; 2012 Aug; 287(36):30181-90. PubMed ID: 22791717
[TBL] [Abstract][Full Text] [Related]
4. Protocatechuic acid inhibits hepatitis B virus replication by activating ERK1/2 pathway and down-regulating HNF4α and HNF1α in vitro.
Dai XQ; Cai WT; Wu X; Chen Y; Han FM
Life Sci; 2017 Jul; 180():68-74. PubMed ID: 28504115
[TBL] [Abstract][Full Text] [Related]
5. Luteolin Inhibits Hepatitis B Virus Replication through Extracellular Signal-Regulated Kinase-Mediated Down-Regulation of Hepatocyte Nuclear Factor 4α Expression.
Bai L; Nong Y; Shi Y; Liu M; Yan L; Shang J; Huang F; Lin Y; Tang H
Mol Pharm; 2016 Feb; 13(2):568-77. PubMed ID: 26656210
[TBL] [Abstract][Full Text] [Related]
6. Green tea polyphenol, epigallocatechin-3-gallate, possesses the antiviral activity necessary to fight against the hepatitis B virus replication in vitro.
Pang JY; Zhao KJ; Wang JB; Ma ZJ; Xiao XH
J Zhejiang Univ Sci B; 2014 Jun; 15(6):533-9. PubMed ID: 24903990
[TBL] [Abstract][Full Text] [Related]
7. Epigallocatechin gallate inhibits hepatitis B virus infection in human liver chimeric mice.
Lai YH; Sun CP; Huang HC; Chen JC; Liu HK; Huang C
BMC Complement Altern Med; 2018 Sep; 18(1):248. PubMed ID: 30189898
[TBL] [Abstract][Full Text] [Related]
8. (-)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes.
Huang HC; Tao MH; Hung TM; Chen JC; Lin ZJ; Huang C
Antiviral Res; 2014 Nov; 111():100-11. PubMed ID: 25260897
[TBL] [Abstract][Full Text] [Related]
9. Epigallocatechin-3-gallate opposes HBV-induced incomplete autophagy by enhancing lysosomal acidification, which is unfavorable for HBV replication.
Zhong L; Hu J; Shu W; Gao B; Xiong S
Cell Death Dis; 2015 May; 6(5):e1770. PubMed ID: 25996297
[TBL] [Abstract][Full Text] [Related]
10. The epigallocatechin gallate derivative Y
Liao ZH; Zhu HQ; Chen YY; Chen RL; Fu LX; Li L; Zhou H; Zhou JL; Liang G
J Ethnopharmacol; 2020 Sep; 259():112852. PubMed ID: 32278759
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of hepatitis B Virus replication by hepatocyte nuclear factor 4-alpha specific short hairpin RNA.
He F; Chen EQ; Liu L; Zhou TY; Liu C; Cheng X; Liu FJ; Tang H
Liver Int; 2012 May; 32(5):742-51. PubMed ID: 22340507
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-35 stimulates hepatitis B virus transcription and replication by targeting transcription factor HNF4α.
Tao NN; Gong R; Chen X; He L; Ren F; Yu HB; Chen J; Ren JH
J Gen Virol; 2018 May; 99(5):645-654. PubMed ID: 29561254
[TBL] [Abstract][Full Text] [Related]
13. Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases.
Sah JF; Balasubramanian S; Eckert RL; Rorke EA
J Biol Chem; 2004 Mar; 279(13):12755-62. PubMed ID: 14701854
[TBL] [Abstract][Full Text] [Related]
14. Novel function of SART1 in HNF4α transcriptional regulation contributes to its antiviral role during HBV infection.
Teng Y; Xu Z; Zhao K; Zhong Y; Wang J; Zhao L; Zheng Z; Hou W; Zhu C; Chen X; Protzer U; Li Y; Xia Y
J Hepatol; 2021 Nov; 75(5):1072-1082. PubMed ID: 34242702
[TBL] [Abstract][Full Text] [Related]
15. Green tea (-)-epigallocatechin gallate inhibits the growth of human villous trophoblasts via the ERK, p38, AMP-activated protein kinase, and protein kinase B pathways.
Shih LJ; Chen TF; Lin CK; Liu HS; Kao YH
Am J Physiol Cell Physiol; 2016 Aug; 311(2):C308-21. PubMed ID: 27147558
[TBL] [Abstract][Full Text] [Related]
16. Epigallocatechin-3-gallate (EGCG) inhibits PC-3 prostate cancer cell proliferation via MEK-independent ERK1/2 activation.
Albrecht DS; Clubbs EA; Ferruzzi M; Bomser JA
Chem Biol Interact; 2008 Jan; 171(1):89-95. PubMed ID: 17931610
[TBL] [Abstract][Full Text] [Related]
17. Interferon-induced polarization of M1 macrophages mediates antiviral activity against the hepatitis B virus via the hepcidin-ferroportin axis.
Liu Q; Li J; Zong Q; Duan Z; Liu F; Duan W; Ruan M; Zhang H; Liu Y; Zhou Q; Wang Q
Int Immunopharmacol; 2024 Jun; 134():112219. PubMed ID: 38733823
[TBL] [Abstract][Full Text] [Related]
18. Epigallocatechin-3-Gallate Inhibits Matrix Metalloproteinase-9 and Monocyte Chemotactic Protein-1 Expression Through the 67-κDa Laminin Receptor and the TLR4/MAPK/NF-κB Signalling Pathway in Lipopolysaccharide-Induced Macrophages.
Li YF; Wang H; Fan Y; Shi HJ; Wang QM; Chen BR; Khurwolah MR; Long QQ; Wang SB; Wang ZM; Wang LS
Cell Physiol Biochem; 2017; 43(3):926-936. PubMed ID: 28957799
[TBL] [Abstract][Full Text] [Related]
19. Rimonabant suppresses RNA transcription of hepatitis B virus by inhibiting hepatocyte nuclear factor 4α.
Sato A; Ono C; Tamura T; Mori H; Izumi T; Torii S; Fauzyah Y; Yamamoto T; Morioka Y; Okuzaki D; Fukuhara T; Matsuura Y
Microbiol Immunol; 2020 May; 64(5):345-355. PubMed ID: 31981244
[TBL] [Abstract][Full Text] [Related]
20. Green tea (-)-epigallocatechin gallate induced growth inhibition of human placental choriocarcinoma cells.
Shih LJ; Lin YR; Lin CK; Liu HS; Kao YH
Placenta; 2016 May; 41():1-9. PubMed ID: 27208402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
